The most useful donations for victims of the California wildfires
Some charities are running out of space for donations from Good Samaritans
All Posts in "Markets"
Shares of banks, small-cap companies fall in London stock market amid Brexit turmoil
Pound headed for its biggest one-day loss since June of 2017
Asian markets mixed, as chip-maker stocks fall
Nikkei and Hang Seng dip, while mainland China stocks gain
GE’s stock surges to best day in months after Baker Hughes stake sale
Stock surge follows 14-day stretch in which there were 13 declines for a total loss of 37%
Elon Musk’s ‘Teslaquila’ may face roadblock from tequila industry
Mexican tequila-industry group opposes trademark application
CannTrust makes its case as a major Canadian weed producer
CannTrust sold C$500,000 worth of recreational pot in third quarter, as much as Aurora, and says it is pursuing a listing on NYSE
Cisco turns concerns into positives with strong earnings
But more tariffs in January could be ‘bad for everybody’
Snap facing regulatory scrutiny over pre-IPO disclosures
SEC, Justice Dept. may be investigating claims of improper disclosures
Why you should change your internet router password now
Your home network could be used to send harmful spam
Tilray revenue doubled but losses widened ahead of legal pot sales in Canada
Earnings report shows Tilray sold 1,613 kilograms of pot in the third quarter
Despite cash infusion, Windtree still faces money running out within a year
Pain medicine biotech Latigo taps CRO founder for CMO role
Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B
Talus Bio tacks on $11M to target hard-to-reach transcription factors
Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA
Denmark’s Adcendo signs $1B biobuck deal for Multitude’s anti-TF ADC
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues
Avantor sells clinical services unit to private equity firm for $650M
‘We’re pretty prolific’: Lilly Catalyze360 looks to connect with emerging biotechs across ‘all areas’
FDA clears its first at-home blood test for syphilis